[Recommendation for standardized medical care for children and adolescents with long COVID].
Töpfner, Nicole, Deutsche Gesellschaft für Pädiatrische Infektiologie e. V. (DGPI), Alberer, Martin et al. · Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde · 2022 · DOI
Quick Summary
This guideline provides doctors with expert recommendations for recognizing and treating long COVID in children and teenagers. It includes screening questions and step-by-step evaluation tools to help identify long COVID cases, as well as guidance on how different medical specialists should work together to care for affected young people. The recommendations are based on the best available evidence, though more research is still needed.
Why It Matters
This guideline addresses a critical gap in pediatric long COVID care by providing standardized, coordinated clinical recommendations across multiple specialties. For ME/CFS patients and researchers, it recognizes the distinct features of long COVID/ME/CFS in young people and emphasizes the importance of PEM assessment, which is central to ME/CFS diagnosis and management.
Observed Findings
Development of time and resource-efficient screening questionnaire for long COVID in pediatric patients
Structured diagnostic evaluation protocol recommended for suspected long COVID cases
Multidisciplinary management approach involving 19 different pediatric medical specialties
Specific assessment tools for post-exertional malaise and myalgic encephalomyelitis/chronic fatigue syndrome identified
Online resources and additional questionnaires made available through DGKJ and DGPI websites
Inferred Conclusions
Standardized screening and structured evaluation protocols are essential for consistent identification of long COVID in children and adolescents
Multidisciplinary collaboration across pediatric specialties is necessary for appropriate management of the complex clinical presentation of long COVID
Post-exertional malaise assessment should be integrated into routine long COVID screening and evaluation in young patients
Current evidence base for pediatric long COVID management remains limited and requires further clinical research
Remaining Questions
What is the diagnostic accuracy and clinical utility of the proposed screening questionnaire in real-world pediatric practice?
What This Study Does Not Prove
This guideline does not establish new efficacy data for specific treatments or diagnostic tests, as it is consensus-based rather than original research. It cannot prove causation or provide epidemiological data about long COVID prevalence or incidence in children. The recommendations are based on limited existing evidence, so some recommendations are expert opinion rather than robust clinical trial data.
How does the effectiveness of different multidisciplinary management approaches compare across different clinical presentations of long COVID in children?
What long-term outcomes result from implementation of these standardized clinical recommendations?
How should treatment approaches differ between long COVID and ME/CFS in pediatric patients?